Alpha Tau Medical Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K covers the month of August 2026, with a specific reporting date of August 10, 2026. Alpha Tau Medical Ltd., a foreign private issuer based in Jerusalem, Israel, filed this report to disclose a material corporate event.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate action rather than a financial results statement.
Material Changes
The primary material change disclosed is the Company's registration for a dual listing on the Tel Aviv Stock Exchange (TASE), as announced in a press release issued on August 10, 2026.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future performance, or a discussion of risks and contingencies beyond the context of the dual listing announcement. No unusual items were reported in this document.
Investor Verification Checklist
- Verify the status and expected timeline of the dual listing on the Tel Aviv Stock Exchange (TASE).
- Review the attached press release (Exhibit 99.1) for details on the listing process and potential impact on share liquidity.
- Confirm the Company's continued compliance with Form 20-F reporting requirements as indicated in the filing.